MSC2504877
MSC2504877 (M2912) is a potent and orally active tankyrase inhibitor with IC50s of 0.0007, 0.0008, 0.54 µM for TNKS, TNKS2, PARP1, respectively. MSC2504877 increases the expression of AXIN2 and TNKS protein levels and decreases β-catenin levels. MSC2504877 shows anti-tumor activity[1].
Product Specifications
CAS Number
1460286-21-8
Product Name Alternative
M2912
UNSPSC
12352005
Target
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/msc2504877.html
Concentration
10mM
Purity
99.25
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C1C2=CC=C(C)N2C=C(C3=CC=C(C(C)(O)C)C=C3)N1
Molecular Formula
C17H18N2O2
Molecular Weight
282.34
References & Citations
[1]Menon M, et al. A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors. Sci Rep. 2019 Jan 17;9 (1) :201.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PARP1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD117 / c-Kit (Marker for Gastrointestinal Stromal Tumors) (KIT/2669), CF647 conjugate, 0.1mg/mL
CD56 / NCAM (NCAM1/795), Biotin conjugate, 0.1mg/mL
Apc5 (ANAPC5) (NM_016237) Human Over-expression Lysate
Cardiac Troponin T (TNNT2) (NM_001001432) Human Recombinant Protein
